PCA
ZBH icon

Peddock Capital Advisors’s Zimmer Biomet ZBH Stock Holding History

Peddock Capital Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,841
Closed -$575K – 167
2025
Q3 		$575K Buy
5,841
+421
+8% +$41.7K 0.12% 101
2025
Q2 		$494K Sell
5,420
-1,434
-21% -$139K 0.11% 106
2025
Q1 		$776K Buy
6,854
+662
+11% +$70.8K 0.2% 88
2024
Q4 		$654K Buy
+6,192
New +$664K 0.16% 91

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Peddock Capital Advisors's ZBH Position: Q4 2025 in Review

Peddock Capital Advisors sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 5,841 shares — an estimated $575K sold.

Peddock Capital Advisors first reported a position in ZBH in Q4 2024 and held it in 4 quarters. The position peaked at $776K in Q1 2025. 945 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.

  • Peddock Capital Advisors reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
  • Peddock Capital Advisors sold 5,841 Zimmer Biomet shares in Q4 2025, an estimated $575K.
  • Peddock Capital Advisors first reported a position in Zimmer Biomet in Q4 2024 and held it in 4 quarters.
  • Peddock Capital Advisors's Zimmer Biomet position peaked at $776K in Q1 2025.
  • 945 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.

Based on Peddock Capital Advisors's 13F filing for Q4 2025, filed 21 Jan 2026.